http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2008068906-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02 |
| filingDate | 2007-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2008068906-A1 |
| titleOfInvention | Mesothelioma diagnostic agent, mesothelioma diagnostic kit, and mesothelioma diagnostic method |
| abstract | The present invention is more sensitive than the mesothelioma diagnostic kits reported so far, distinguishing from healthy individuals, distinguishing mesothelioma patients from those who have experienced asbestos exposure, patients with other diseases such as lung cancer It is an object of the present invention to provide a mesothelioma diagnostic agent and the like that can be effectively distinguished from each other. The present invention comprises an antibody that recognizes an N-terminal fragment of a fragment produced by leaving 31 kDa secreted Erc / MPF / mesothelin as blood or separated into serum at room temperature for 3 hours or more. The present invention relates to a diagnostic agent for dermatoma. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015134764-A |
| priorityDate | 2006-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.